{
    "radiographic_examinations": [
        {
            "procedure_name": "Barium swallow examination",
            "date": "Not specified",
            "findings": "Annular constriction (3 to 4 cm in length) with irregular mucosal contours involving the distal esophagus and gastroesophageal junction, suggestive of esophageal cancer.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT scan and PET scan",
            "date": "Not specified",
            "findings": "Intense 18F-fluorodeoxyglucose (FDG) uptake involving the distal esophagus and gastroesophageal junction, as well as lymphadenopathy with intense FDG uptake in mediastinal, retrocrural, and retroperitoneal regions.",
            "changes_over_time": "Initial findings suggest intense FDG uptake, which later showed evidence of disease progression with similar intense uptake after treatment with FOLFOX and radiation therapy."
        },
        {
            "procedure_name": "CT of the chest, abdomen, and pelvis",
            "date": "After treatment with FOLFOX and radiation therapy",
            "findings": "Decreased thickening of the esophageal wall and diminishing mediastinal and retroperitoneal lymphadenopathy.",
            "changes_over_time": "Suggestive of a response to treatment."
        },
        {
            "procedure_name": "Follow-up PET-CT",
            "date": "Three months later",
            "findings": "Evidence of disease progression, including multiple hepatic, pulmonary, and adrenal metastases with intense FDG uptake.",
            "changes_over_time": "Indicated worsening disease after initial improvement."
        },
        {
            "procedure_name": "Follow-up PET-CT after therapy with MET inhibitor",
            "date": "Not specified",
            "findings": "Marked response to treatment indicated by resolution of hepatic, adrenal, pulmonary, and nodal metastases.",
            "changes_over_time": "Showed a radiographic complete response since the eighth month of treatment."
        }
    ]
}